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All rigObjectives. Modern conventional ultrasound is sensitive to slow flow, but may misclassify some tight stenoses as occlu-
sion. Symptomatic patients with tight proximal internal carotid artery stenoses may benefit from carotid endarterectomy
but those with occlusion or long-segment disease do not.
Design. A prospective study of the diagnostic accuracy of contrast-enhanced ultrasound (CE-US), 2D time-of-flight
magnetic resonance angiography (2D-TOF MRA) and contrast-enhanced magnetic resonance angiography (CE-MRA)
against a reference standard of digital subtraction angiography (DSA) in patients with apparent carotid occlusion on
conventional ultrasound.
Materials and methods. Thirty-one patients with apparent carotid occlusion on conventional ultrasound and with recent
ispilateral hemispheric transient ischaemeic attacks (TIAs) were studied. The primary endpoint was confirmation of occlu-
sion with a secondary endpoint of identification of a surgically correctible lesion.
Results. The sensitivity and specificity of CE-US, 2D-TOF MRA and CE-MRA for patency were 1 & 1, 0.33 & 1 and 0.6
& 1 respectively and for the detection of a surgically correctible lesion were 1 & 0.96, 0.67 & 1 and 1 and 0.96 respectively.
CE-US was difficult to interpret, precluding confident diagnosis in 5 cases.
Conclusions. 2D-TOF MRA had poor sensitivity for patency and cannot be recommended as a second-line investigation
to assess vessels apparently occluded on conventional ultrasound. Confident diagnosis on CE-US and CE-MRA accurately
identified occlusion. If occlusion is confirmed by either of these modalities, no further imaging is required. The relative
advantages of CE-US or CE-MRA in this situation are uncertain.
Crown Copyright  2008 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All rights
reserved.
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tomy, carotid.Introduction
The role of carotid endarterectomy (CEA) in reducing
the stroke and death rates in patients with a significant
(>70%) symptomatic internal carotid artery (ICA)
stenosis is well established.1e3 Patient selection in
these trials was based upon selective carotid digital-
subtraction angiography (DSA). Patients with an ipsi-
lateral carotid occlusion were considered unsuitable
for surgery. In theory, with a stenosis of 95% the like-
lihood of distal embolization is reduced because ofsponding author. Dr. S. J. McPherson (Consultant Vascular
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hts reserved.low flow, although the risk of watershed ischaemia
may increase. CEA in these patients remains contro-
versial, conferring only a marginal benefit over best
medical therapy in the short term (up to 5 years).3
Further, the annual incidence of ipsilateral stroke in
patients with an occluded ICA on conventional US
(in the absence of ongoing symptoms) is only 2%.4
Nevertheless, many clinicians would offer surgery to
patients with apparent carotid occlusion on conven-
tional US if near-occlusion (rather than true occlusion)
was found on confirmatory DSA5,6 in the face of
recent ipsilateral hemispheric TIAs despite maximal
medical therapy7 and evidence of hemispheric perfu-
sion from the ipsilateral ICA. It remains critical there-
fore, to establish whether the ICA is occluded or has
a tight stenosis. If the ICA is patent, clarification as
to whether the ICA stenosis is focal, affects a longby Elsevier Ltd on behalf of European Society for Vascular Surgery.
406 C. J. Hammond et al.length of the extracranial ICA or is associated with
a tandem lesion of the distal ICA is required.
The presence of flow in the cervical ICA on conven-
tional ultrasound (including 2D, colour and power
Doppler ultrasound) is a sensitive marker for patency
in this vessel.8 The reference standard for assessing
carotid stenotic lesions (and confirming occlusion) has
been selective digital-subtraction angiography but this
is an invasive procedure and is associated with a small
risk of post-angiography stroke.9 The ability of contrast-
enhanced ultrasound and magnetic-resonance angiog-
raphy to distinguish occlusion from near-occlusion
and surgical from non-surgical lesions has not been
investigated in the group of patients with apparent
ICA occlusion on conventional US, despite the fact
that about 3% of symptomatic patients attending for
US of the ICAwill fall into this group.4
This study prospectively examines the accuracy of
contrast-enhanced ultrasound (CE-US), 2D time-of-
flight (2D-TOF MRA) and contrast-enhanced MRA
(CE-MRA) against a reference standard of selective
contrast angiography in symptomatic patients whose
ipsilateral ICA was apparently occluded on conven-
tional US. Our primary criterion for accuracy was the
assessment of patency, with a secondary criterion of
detecting a stenosis suitable forCEAasdefinedbyDSA.Materials and Methods
The study group was recruited from patients referred
for carotid ultrasound because of focal hemispheric
neurological symptoms (TIA or minor stroke) within
the previous six months. Symptomatic patients with
non-disabling neurology and an apparent carotid
occlusion on US (technique as described in Table 1)
ipsilateral to the symptomatic cerebral hemisphere
who were fit for CEA were invited to participate in
the study provided that informed consent was obtain-
able and there was no contraindication to MRI or an-
giography (eg. metallic implants, absent femoral
access, allergy to iodinated contrast medium).
The study group underwent further carotid imag-
ing as described below. All tests were completed
within 14 days using the methods described in Table 1.
Patients failing to undergo their investigations within
this time frame were excluded from the study.
1. Repeat conventional US ‘confirm’ ICA occlusion
(technique identical to that for first scan)
2. Contrast enhanced US
3. 2D time-of-flight MRA
4. 3D contrast-enhanced MRA
5. Selective digital-subtraction angiographyEur J Vasc Endovasc Surg Vol 35, April 2008Tests 1 and 2 (US) were dual reported at the time of
scanning by an experienced vascular sonographer
and a consultant vascular radiologist in an unblinded
manner. Vessels were characterised as definitely
occluded (if no flow was seen anywhere within the
cervical ICA) or definitely patent (if a flow channel
was seen throughout the cervical ICA). Disagreement
was resolved at the time of scanning by consensus
and was not recorded.
Tests 3 and 4 (MRA) were dual reported by two
consultant vascular radiologists in a blinded manner.
Image review occurred at a workstation, making
reference to source data, whole-volume and sub-
volume maximum-intensity-projections, operator
defined multi-planar reformats and other post-
processing as required. Vessels were characterised as
definitely patent if signal could be identified within
the cervical ICA in continuity with the siphon (small
focal flow gaps were allowed as long as distal signal
was preserved) or definitely occluded if no signal
could be identified in the line of the cervical ICA. Ves-
sels characterised as definitely patent were further
classified into four groups on the basis of their appar-
ent suitability for CEA: (a) probably suitable for CEA
(proximal stenosis with good calibre distal ICA); (b)
possibly suitable for CEA (proximal stenosis with re-
duced calibre distal ICA); (c) probably unsuitable for
CEA (reduced calibre ICA, possible tandem lesions);
(d) not suitable for CEA (diffuse narrowing, multicen-
tric stenoses). Both the 2D-TOF and CE-MRA datasets
were used for this subjective assessment.
Inter-observer error for these 2 assessments was
assessed by using the kappa statistic. Disagreement
regarding patency versus occlusion was resolved by
consensus review of the images.
Test 5 (DSA) was singly reported by a consultant
vascular radiologist at a workstation with reference
to digital data and hardcopy film. Vessels were char-
acterised as definitely patent if a linear contrast col-
umn of any thickness could be seen from the origin
of the cervical ICA to the siphon in the absence of
backfilling from intracranial vessels. Vessels were
characterised as definitely occluded if no contrast
could be identified in the line of the cervical ICA or
if there was significant discontinuity with backfilling
of the siphon and distal ICA from the intracranial
vessels. The suitability of patent vessels for CEA
was defined using the same criteria as those for
MRA, with the addition of the assessment of filling
of intracerebral vasculature from the ipsilateral side.
CEA was performed when an isolated focal proxi-
mal stenosis was demonstrated with a good or moder-
ate calibre smooth distal ICA in symptomatic patients.
The patency of the vessel at surgery was recorded.
Table 1. Details of techniques used
Test Details
Conventional US (test 1) Acuson 128 XP10 US machine
7 MHz linear array transducer
B mode and colour and power Doppler images used for superimposed simultaneous flow information
on greyscale images.
Beam focussing at level of vessel being investigated. Lowest possible pulse repetition frequency (PRF)
without aliasing. Maximum colour and power gain without background noise.
Adjustments to gain and transmission power (increased) and wall filter and PRF (decreased) if no flow
seen under standard conditions.
Pulsed Doppler for velocity profile assessment using angle of insonation <60 degrees.
Standardised sequential longitudinal and axial views of the entire extracranial carotid system using
greyscale, colour and spectral modalities
Contrast enhanced US (test 2) US contrast agent: Levovist (Schering, UK) e 99.9% galactose, 0.1% palmitic acid, as granules
Otherwise equipment as for test 1
2.5 g vial of Levovist prepared according to manufacturers instructions with 5 ml water for injections,
reconstituting to make 6.5 ml Levovist 400
Solution injected at 1 ml/second via indwelling 18 or 20 G iv cannula in the antecubital vein
Scan protocol thereafter as per conventional US
2D-TOF MRA (test 3) Philips ACS NT MRI scanner at 1.5 Tesla
Quadrature neck coil
2D FFE inflow technique
Scan parameters: TR 25 ms, TE 7 ms, Flip angle 25deg, FoV 22 cm, RFoV 80%, Matrix 256 256, Slice
thickness 3/1, axial scan plane
CE-MRA (test 4) MR contrast agent: Magnevist (Schering, UK) e gadopentetic acid in solution
Otherwise equipment as for test 3
30 ml Magnevist (14.1 g), followed by 20 ml saline chaser injected by automated injector at 1 ml/second
via indwelling 18 or 20 G iv cannula in the antecubital vein
Scan parameters: Spoiled GE sequence: TR 5 ms, TE 1.5 ms, Flip angle 40deg, FoV 22 cm, RFoV 80%,
Matrix 512 200, Slice thickness 1/0.5, Phase order low-high (centric k-space filling), Scan initiation
Bolus-Trak, coronal scan plane.
DSA (test 5) Siemens Angiostar vascular suite
Angiographic catheters as available/needed
Angiographic contrast agent: Ultravist 370 e lopromide 370 mg/ml
Outpatient examination unless contraindicated
1 l normal saline as prehydration via iv cannula
4Fr puncture into common femoral artery. Insertion of 4Fr sheath. Pigtail catheter advanced to arch.
Arch injection (25 ml contrast at 15 ml/min) to assess ostia of carotids followed by selective cannulation
of common carotid artery with various catheters (as appropriate) over soft hydrophilic guidewire.
Assessment of cervical carotid (at least 2 views) and intracranial circulation following selective injection
of 10 ml diluted contrast (to approx. 300 mg/ml). Imaging rate of 2 frames/sec with prolonged runs
to detect faint antegrade flow in carotid.
Patient discharged home after two hours observation in recovery area and if puncture site and
neurology satisfactory. Data archived electronically onto compact disc and stored.
407Assessment of Apparent ICA Occlusion on UltrasoundSensitivity and specificity were calculated for each
technique against DSA for its ability to detect patency
and a surgically correctible lesion. Calculations were
made using pre-prepared worksheets in Microsoft
Excel.
The study had local ethical committee approval.
Results
Between April 2001 and August 2004, 56 patients
agreed to participate. Three of these 56 patients had
apparent bilateral ICA occlusions diagnosed on their
initial conventional US, making a total of 59 vessels
enrolled into the study. Nineteen vessels were
excluded on the basis of incomplete imaging due to
patient failure to attend (8 vessels), claustrophobia
and inability to tolerate MRA (10 vessels), or refusalto consent to DSA (1 vessel). A further 9 vessels were
excluded because there was a delay of >14 days in
completing of their imaging. Thus 31 vessels (in 30
patients) underwent all 5 imaging tests with a median
delay (from initial confirmatory US) of 1 day (range 0e
9 days) to MRA and 0 days (range 0e9 days) to DSA.
Reference standard e DSA and decision to operate
DSA confirmed carotid occlusion in 25/31 (81%) ves-
sels (Fig. 1a). Of the remaining 6 patent vessels, 2 were
very irregular, with filling of the intracranial vessels
from the contralateral side or from external carotid
artery (ECA) collaterals via the ophthalmic artery.
These vessels were considered unsuitable for CEA.
A third patent vessel with an irregular distal lumen
was also classified as unsuitable for CEA.Eur J Vasc Endovasc Surg Vol 35, April 2008
Fig. 1. a: DSA following left common carotid artery injection
demonstrating a small stump of proximal ICA (arrow) with
no demonstrable flow beyond it, indicating a proximal ICA
occlusion. b: Surface shaded maximum-intensity projection
CE-MRA of the left CCA, ICA and ECA, demonstrating
a small stump of proximal ICA (arrow) with no demonstra-
ble signal beyond it, indicating proximal ICA occlusion
(same patient as Fig. 1a).
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ses with smooth collapsed lumens beyond these, with
flow into the ipsilateral middle cerebral artery. These
were considered suitable for CEA (Fig. 2a) and 2 pa-
tients with recurrent ipsilateral hemispheric symptoms
underwent surgery. The third patient in this group did
not undergo surgery as his on-going symptoms were
related to the contralateral cerebral hemisphere. No
other patients underwent CEA. At surgery, both oper-
ated vessels were found to be patent.
Conventional-US
All patients enrolled into the study had their apparent
carotid occlusion confirmed at confirmatory conven-
tional US (test 1).
CE-US
A confident diagnosis could not bemade in 5/31 (16%)
vessels. Two investigations were technically inade-
quate due to patient movement or contrast flooding.
In 3 vessels there was uncertainty in distinguishing
between patency and occlusion. These investigations
were classified as non-diagnostic. In the 26 remaining
vessels, 24 were classified as definitely occluded and
2 as definitely patent.Eur J Vasc Endovasc Surg Vol 35, April 2008Table 2 compares assessment of patency by CE-US
with DSA. When the diagnosis of patency or occlusion
was confident, this agreed with DSA in all cases. The
sensitivity of a confident diagnosis of patency or occlu-
sion versus DSA is therefore 1, with a specificity of 1.
When patent but non-surgically correctible lesions
are accounted for the sensitivity of confident CE-US
diagnosis this versusDSA is 1, with a specificity of 0.96.
2D-TOF MRA
All 2D TOF MRA examinations were technically ade-
quate. Inter-observer agreement of assessment of
patency was substantial (k¼ 0.65). There was a single
vessel over which there was disagreement. The con-
sensus was that the vessel was patent on 2D-TOF
MRA. This vessel was suitable for CEA on DSA.
Following consensus, 2 ICAs were characterized as
patent and 29 as occluded. Four of these were patent
on DSA including 1 which was suitable for CEA.
These results are summarised in Table 3a.
The sensitivity of 2D-TOF MRA to detect patency is
therefore 0.33 with a specificity of 1. Even for identify-
ing arteries with a surgically correctible lesion, the
sensitivity was 0.67, again with a specificity of 1. Ex-
clusion of the vessel over which there was disagree-
ment would have reduced sensitivity further.
CE-MRA
A single CE-MRA examination was abandoned due to
coil failure after the 2D-TOF images had been
obtained. This vessel was suitable for CEA on DSA.
Inter-observer agreement of assessment of patency
was good (k¼ 0.78). There was a single vessel over
which there was disagreement. The consensus was
that the vessel was patent on CE-MRA. Although this
vessel was patent on DSA, it was unsuitable for CEA.
Following consensus, 3 ICAs were characterized as
patent (Fig. 2b) and 27 as occluded (Fig. 1b), 2 of which
were patent on DSA. Neither of these vessels was suit-
able for CEA. Thus CE-MRA correctly identified 3 pat-
ent vessels, 2 of which were suitable for CEA on DSA.
The sensitivity of CE-MRA to detect patency versus
DSA is therefore 0.6 with a specificity of 1, and 1 and
0.96 respectively for identifying a surgically correcti-
ble lesion (Table 3b).
Interobserver assessment of suitability of ICA
stenosis for CEA on MRA
Therewasnoagreement (k¼ 0) regarding the suitability
for CEA of the three vessels characterised as patent on
Fig. 2. a: DSA immediately following left common carotid injection (left hand pane) with subsequent (middle pane) and
delayed (right hand pane) images of the same region. There is a tight focal stenosis of the proximal ICA (arrow) with for-
ward flow of contrast along a smooth walled distal ICA (arrowheads) beyond the stenosis. The delayed image shows con-
trast arriving at the siphon with no evidence of backfilling of unopacified blood from the other side. The left middle cerebral
artery filled from the left CCA injection. This patient underwent CEA. b: Surface shaded maximum-intensity projection CE-
MRA of the left CCA, ICA and ECA, demonstrating a tight proximal ICA stenosis within which there is no discernible sig-
nal (arrow) but with good filling of the ICA distal to this (arrowheads) up to the carotid siphon (same patient as Fig. 2a).
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mation, inability to assess filling of the cerebral vascula-
ture and the lower spatial resolutionofMRA, compared
with DSA, made this assessment very difficult.
Discussion
Modern duplex ultrasound is very sensitive to flow.
Mansour et al.8 reported a sensitivity of over 99% for
detecting ICA patency relative to a reference standard
of selective DSA. Others have described similar re-
sults for US in patients known to have a tight stenoses
on DSA.10 The relatively small size of our study stems
from this high sensitivity of US to flow since patients
with a patent ICA on US were never candidates for
inclusion.
Of the 31 vessels in our study, only 6 were sub-





DSA Patent 2 0 4
Occluded 0 24 1
DSA (suitability for
CEA)
Suitable 1 0 3
Unsuitable 1 24 2(10%) were suitable for CEA. In the face of this low
incidence of surgically correctible lesions in arteries
said to be occluded on conventional US, and the
potential risks of DSA, particularly in patients with
severe carotid disease,6 the question arises as to
how to identify patients who might benefit from
CEAwhilst minimising the number undergoing angi-
ography. A pre-angiography screening test is required
with a false-negative rate of zero (thereby identifying
all potential surgical candidates). An occluded vessel
would therefore require no further imaging. If appar-
ently patent vessels then proceed to angiography, the
false-positive rate need not be zero, but should be as
close to this as possible. In other words, the sensitivity
of the test for patency (or for a surgically correctible
lesion) should be unity relative to DSA, with a second-
ary requirement that it is to be specific enough to




DSA Patent 2 4
Occluded 0 25
DSA (suitability for CEA) Suitable 2 1
Unsuitable 0 28
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DSA Patent 3 2
Occluded 0 25
DSA (suitability for CEA) Suitable 2 0
Unsuitable 1 27
The 1 patient with coil failure is not included.
410 C. J. Hammond et al.considering the performance of CE-US, 2D-TOF MRA
and CE-MRA.
Contrast-enhanced ultrasound
Echo enhancement agents such as Levovist consist of
microbubbles suspended in the plasma and increase
the strength of echoes returned from blood by up to
30 dB.11 Several studies have evaluated the use of
ultrasound contrast agents in the assessment of severe
carotid stenosis and occlusion12e15 confirming ease of
use and increased visualization of flow compared to
conventional US. Sensitivities of CE-US for patency
of 0.83e1 are reported. However, none of these studies
are comparable to ours as they included patients with
a patent but tightly stenosed ICA on conventional US.
Such patients were excluded from the present study
which is confined to a population with more extreme
disease. This may explain the relatively high rate of
non-diagnostic/equivocal investigations in this group.
Ferrer et al.16 have reported a further study of 85
patients with apparent ICA occlusion on conventional
US with a reference standard of DSA or surgical
exploration. A confident diagnosis of patency (7 ves-
sels) or occlusion on CE-US was made in all cases,
with no cases in which patency was uncertain and
no technical failures. Further, CE-US agreed with the
reference standard in all patients (sensitivity and
specificity of 1) and the authors concluded that DSA
need only be used in exceptional cases. To some
extent, these findings mirror the results reported
here with all patent and all occluded vessels correctly
identified by CE-US when the operator was confident
of the diagnosis. However, in our study, of 2 vessels
identified as patent by CE-US only 1 was suitable
for CEA, an outcome not reported by Ferrer et al.
Thus we cannot recommend CEA simply on CE-US
confirmed ICA patency. In addition, CE-US did not
make a conclusive diagnosis in 5 vessels. This oc-
curred despite CE-US being performed independently
by 2 highly experienced vascular sonographers.
As a result 7/31 vessels (23%) in this studywould re-
quire further investigation to reach a definitive conclu-
sion as to the suitability of the vessel for CEA.AlthoughEur J Vasc Endovasc Surg Vol 35, April 2008a protocol of CE-US followedbyDSA in vessels not def-
initely occluded would ensure that no vessels suitable
for CEA are missed, 1 in 4 vessels would require DSA.2D-TOF magnetic resonance angiography
A 2D- rather than 3D-TOF sequence was selected as it
is more sensitive to slow flow in highly stenotic
arteries due to the lack of in-volume flow-saturation
effects.12,17 Despite this 2D-TOF MRAwas insensitive
(sensitivity¼ 0.33) for the detection of patency in this
cohort of patients. This low sensitivity may reflect
very slow flow through a tight stenosis, resulting in
decreased inflow of unsaturated blood into the imag-
ing slice and consequent loss of signal, or in-stenosis
and post-stenotic turbulent flow also which contrib-
utes to signal loss in TOF-MRA.18
Prospective studies of near-occlusion on DSA
report sensitivities for patency of 2D-TOF MRI of
0.65e0.95.12,17 These are better than those reported
here but again reflect the proportion of study patients
who had a patent ICA on conventional US. It is
expected that the more advanced atherosclerosis in
our study group would be associated with slower
flow and an increased likelihood of signal loss and
misclassification. There have been no previous studies
evaluating the performance of 2D-TOFMRI in a popu-
lation such as the one reported here. The low sensitiv-
ity of 2D-TOF MRA for both vessel patency and
a surgically correctible lesion means that this modal-
ity cannot be recommended as a screening tool,
following conventional US, to reduce the requirement
for DSA. Such a policy would result in 1 in 3 vessels
with a correctible lesion being misclassified as
occluded and not investigated further.CE-MRA
Contrast enhanced MRA relies on contrast agent
mediated T1 shortening of blood to define vessel anat-
omy. It overcomes the problem of signal loss due to
slow-flow and turbulence and is less likely to overes-
timate stenoses.19 This is confirmed by its improved
performance over 2D-TOF MRA in detecting patency
in the present study.
Although numerous studies have assessed the
performance of CE-MRA versus DSA in unselected
populations, with reported sensitivities for the detec-
tion of near-occlusion (as opposed to occlusion) of
0.78e1,17,20e22 none have evaluated its performance in
patients with apparent ICA occlusion on conventional
US. Our sensitivity of 0.6 (for the detection of patency)
is outwith this range but, is again likely to reflect the
411Assessment of Apparent ICA Occlusion on Ultrasoundmore severe disease in our patient group. Despite this
apparently disappointing result we found that CE-
MRA successfully identified all patients inwhomapat-
ent ICAwas suitable for CEA. This finding is crucial.
Of the 3 patent vessels on CE-MRA, only 2 were
deemed suitable for CEA on subsequent DSA and
thus surgery cannot be recommended on the basis
of patency alone. ICA flow and ipsilateral cerebral fill-
ing are important factors in assessing surgical suitabil-
ity and this dynamic information is unavailable on
non-time resolved MRA. 3/30 (10%) ICAs scanned
with CE-MRA would therefore need DSA to ensure
that the option of CEA is never missed. However, 10
vessels in the originally recruited cohort could not
be scanned due to patient inability to tolerate MRA.
If these vessels are taken into account then 13 of 59
vessels (22%) would require DSA.
Clinical utility of CE-US, 2D-TOF MRA and CE-MRA
2D-TOF cannot be recommended as a second line
screening investigation following conventional US as
it lacks sensitivity. CE-US and CE-MRA identified all
potential candidates for CEA with about 1 in 5 pa-
tients requiring subsequent DSA. The relative advan-
tages of a policy of CE-US or CE-MRA as a second line
screening tool are unclear: CE-US can be performed at
the same visit as the conventional US and is an alter-
native to CE-MRA if the patient cannot tolerate or has
other contraindications to MRA. On the other hand, if
a patient can tolerate CE-MRA then a greater propor-
tion of studies are diagnostic.
Other techniques
It has been reported that carotid CT angiography
(CTA) has an excellent correlation with angiography
in differentiating total from near occlusion in an unse-
lected population23 although in a population with
apparent US-detected carotid occlusion the sensitivity
for patency of dual slice CTA is 0.9624 indicating that
a small proportion of patent vessels would be missed
using this technique. At present it cannot be recom-
mended as a second line screening tool. Modern
multislice CTA may offer improved performance al-
though dynamic flow information would be lacking
and DSA would still be required for patent vessels.
The current study did not assess the accuracy of CTA.
Limitations and applicability of the study
The results should be interpreted with some caution
as the study size was small and the recruitment periodprolonged. Further, our first patient was recruited in
2001 and advances in US and MR technology have
made modern scanners more sensitive to slow flow.
Nevertheless, confirmation of apparent carotid occlu-
sion remains an important (albeit infrequent) clinical
issue in patients with recent ipsilateral hemispheric
symptoms. It is likely, but unproven, that improve-
ments in scanning technology have improved the clin-
ical utility of these modalities over that observed in
the current study.Conclusions
The small size of our study, lengthy recruitment
period and the low number of patent vessels empha-
sises the sensitivity of modern conventional US to
flow. When carotid occlusion is identified on conven-
tional US, in the presence of ipsilateral hemispheric
symptoms, confirmation of this diagnosis is required
to prevent patients being denied the opportunity to
benefit from surgery. In order to minimise the number
of patients undergoing angiography, a second line in-
vestigation is required with sensitivity for patency
equivalent to that of DSA, and which is specific
enough to be clinically useful. Vessels that are not def-
initely occluded can then go on to DSA.
Our data suggest that symptomatic patients found
to have an occluded ICA on conventional US confir-
mation of the diagnosis is reliably achieved by CE-
US or CE-MRA. In patients in whom a patent ICA
is identified, angiography is required to accurately as-
sess its suitability for CEA. Definite occlusion on CE-
US or CE-MRA requires no further investigation. The
relative advantages of a policy of CE-US or CE-MRA
as a second line screening tool are uncertain.Acknowledgements
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